NAPWA

A new, once-daily, lower dose of the protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. darunavir (Prezista) is available on the PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. from 1 December.

To date, the recommended dose has been 600mg taken twice-a-day along with 100mg of ritonavir. But this new daily dose is just 800mg boosted with a single dose of ritonavir.

The lower dosage of both drugs appears to have a much better side effectAn unwanted effect caused by the administration of drugs. Onset may be sudden or develop over time. profile. read more »

Adrian Ogier gives the low-down on latest antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatments. read more »

The Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) has extended access to the new protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate., darunavir, now making it an option for more people. read more »